Eline van Diest - Concepedia

Author

Eline van Diest

University Medical Center Utrecht

Also Known As

Diest, Eline van, Eline Van Diest, Eline van Diest

Publications

339

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University University of Freiburg

About

Eline van Diest is an author at University Medical Center Utrecht specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	173
2	Cell Biology	4	4	173
3	Immunology	4	4	173
4	Cellular Therapies	1	1	47
5	Pharmacology	1	1	40

Eline van Diest

Publications

312

Citations

H-Index

Page 1

	Year	Citations
γ9δ2T cell diversity and the receptor interface with tumor cells Anna Vyborova, Dennis X. Beringer, Domenico Fasci, Journal of Clinical Investigation ImmunologyImmune RegulationImmunodominanceImmunologic MechanismImmunotherapeutics	2020	69
γδ T-cell Receptors Derived from Breast Cancer–Infiltrating T Lymphocytes Mediate Antitumor Reactivity Anke Janssen, José Villacorta Hidalgo, Dennis X. Beringer, Cancer Immunology Research	2020	54
Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure Tassilo L A Wachsmann, Anne K. Wouters, Dennis F.G. Remst, OncoImmunology Cell TherapyT-regulatory CellImmunologyImmunoeditingT Cells	2022	47
Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds Eline van Diest, Patricia Hernández López, Angelo D. Meringa, Journal for ImmunoTherapy of Cancer ImmunologyImmune RegulationImmunoeditingImmunologic MechanismTumor Reactivity	2021	40
The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment Leo Hanke, Kevin E. Knockenhauer, R. Camille Brewer, mBio	2016	36
T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticles Jaime Fernández Bimbo, Eline van Diest, Daniel E. Murphy, Journal for ImmunoTherapy of Cancer	2025	25
Serpin B9 controls tumor cell killing by CAR T cells Thomas Kimman, Anne Slomp, Anne W. J. Martens, Journal for ImmunoTherapy of Cancer	2023	24
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells Patricia Hernández-López, Eline van Diest, Péter Brázda, Nature Immunology Cancer ImmunosurveillanceCancer MetabolomeT CellsT-regulatory CellImmunology	2023	17

Page 1